Isolation and characterization of a new cyclic lipopeptide orfamide H from Pseudomonas protegens CHA0

J Antibiot (Tokyo). 2020 Mar;73(3):179-183. doi: 10.1038/s41429-019-0254-0. Epub 2019 Oct 30.

Abstract

A new cyclic lipopeptide (CLP) orfamide H (1) was purified and identified from the cultural broth of the bacterial strain Pseudomonas protegens CHA0. The crude extract of the strain CHA0 was obtained by an acid-aided precipitation process, then the compound 1 was purified by reversed-phase high-performance liquid chromatography (RP-HPLC). Subsequently, the chemical structure of orfamide H was determined by 1D and 2D nuclear magnetic resonance (NMR) and mass spectrometry (MS). Further biological assays indicate that the new CLP orfamide H shows the activity on inhibiting the appressoria formation of the fungus Magnaporthe oryzae, the causal agent of the blast disease in rice. Taken all together, these results indicated that the new CLP orfamide H has the capacity to be developed as an agrichemical to control blast disease in rice.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Peptides, Cyclic / chemistry*
  • Peptides, Cyclic / metabolism*
  • Peptides, Cyclic / pharmacology
  • Protein Conformation
  • Pseudomonas / metabolism*

Substances

  • Peptides, Cyclic

Supplementary concepts

  • Pseudomonas protegens